Direct Costs of Healthcare for Children with Type 1 Diabetes Using a
CGM System: A Health Economic Analysis of the VIDIKI Telemedicine Study in a
German Setting
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Direct Costs of Healthcare for Children with Type 1 Diabetes Using a
CGM System: A Health Economic Analysis of the VIDIKI Telemedicine Study in a
German Setting
Beschreibung:
<jats:title>Abstract</jats:title><jats:p>
Aims The Virtual Diabetes Outpatient Clinic for Children and Adolescents
(VIDIKI) study was a 6-month quasi-randomized, multicentre study followed by an
extension phase to evaluate the effects of monthly video consultations in
addition to regular care. A health economic analysis was conducted to assess the
direct costs.</jats:p><jats:p>
Methods The cost data of 240 study participants (1–16 years of
age) with type 1 diabetes who were already using a continuous glucose monitoring
system were collected in the first 6 months of the study. The intervention group
(IG) received monthly video consultations plus regular care, and the waiting
control group (WG) received only regular care. Cost data were collected for a
comparable anonymized group of children from the participating health insurance
companies during the 6-month period before the study started (aggregated data
group [AG]).</jats:p><jats:p>
Results Cost data were analysed for the AG (N=840) 6 months before
study initiation and those for the study participants
(N=225/240). Hospital treatment was the highest cost category in
the AG. There was a cost shift and cost increase in the IG and WG, whereby
diabetes supplies were the highest cost category. The mean direct
diabetes-associated 6-month costs were € 4,702 (IG) and € 4,936
(WG).</jats:p><jats:p>
Conclusion The cost development within the cost collection period over two
years possibly reflects the switch to higher-priced medical supplies. Video
consultation as an add-on service resulted in a small but nonsignificant
reduction in the overall costs.</jats:p>